Luna Fit
82/100
Ranked #16 for women · Grade B−
Pallas Health review
Names its six dispensing pharmacies and two NPI-verified physicians — disclosure few rows here offer — and then sells the whole thing on a single 12-week prepay whose advertised “$199/mo average” is that prepay divided by three, with no monthly rung to pick instead.
Visit Pallas Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. See our disclosure.
- Semaglutide
- $199/mo average — Pallas's own figure for $597 billed every 12 weeks, which is its only cadence; $139 covers the first 4 weeks, after which the next charge is $597 in one payment
- Tirzepatide
- $299/mo average — Pallas's own figure for $897 billed every 12 weeks, which is its only cadence; $179 covers the first 4 weeks, after which the next charge is $897 in one payment
- Coverage
- All 50 states and Washington D.C. — asynchronous in 43; Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia and D.C. require one video visit
- Brand-name
- Yes
The Luna Fit scorecard
Pallas Health scored on our six women's-health factors. See the methodology.
PCOS & hormonal suitability74/100
Clinical oversight & labs85/100
Price transparency78/100
Nationwide access94/100
Ongoing support78/100
Cancellation fairness84/100
What we like
- Names all six dispensing pharmacies in public — Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills — with the 503A and 503B distinction explained, where almost everything else in this category names none
- Names two prescribing physicians with their NPI numbers and links out to the NPPES registry so you can check them yourself: Dr. Ana Lisa Carr, MD (family medicine, NPI-verified, licensed in 15 states) and Dr. Kelly Tenbrink, MD (emergency medicine, NPI-verified, Tennessee and Florida). Pallas additionally claims obesity and addiction medicine board certifications for Dr. Carr, which NPPES does not carry either way
- The advertised price is the checkout price — the homepage FAQ, the landing pages, the treatment pages and the live funnel all state the same four figures, and no different number appears at payment
- Publishes its coverage precisely instead of as a blanket promise: all 50 states and D.C., fully asynchronous in 43, with the eight jurisdictions that require a video visit named one by one, and a shipping-state eligibility guard in the checkout itself
- Leaving is self-serve and free — a cancellation portal at pallashealth.co/portal, a pre-renewal email reminder, no minimum term, at least 30 days' notice before any price change, and a full refund if a clinician declines you. LegitScript Healthcare Merchant Certified (seal 49989444), and clean against FDA's live warning-letter index under both its own name and its operator's
The caveats
- There is no month-to-month rung. The funnel renders no cadence selector at all: semaglutide is $139 for the first four weeks and then $597 billed every 12 weeks, so the second charge is $597 in one payment four weeks after the first — tirzepatide, $179 then $897 — and the advertised “$199/mo average” is that 12-week prepay divided by three rather than a price anyone is billed
- Twelve weeks is not three months. On Pallas's own published renewal terms the charge recurs every 84 days — 4.35 times a year, not four — so semaglutide's first year is $139 + 4×$597 = $2,527, or $210.58/mo, and the steady state is $2,596 a year, about $216/mo, against $199 advertised. Tirzepatide runs $3,767 in year one ($313.92/mo) and about $3,900 a year after (~$325/mo) against $299. The advertised average understates the ongoing rate by roughly 8.7%
- No women's-health program of any kind. Pallas's own women's-health category exists only as “coming soon”; there is no PCOS track, no perimenopause track and no cycle-aware protocol, and neither named physician is an OB-GYN or a women's-health specialist. What is on offer here is a general compounded GLP-1 program, and it should be read as one
- One of the six named pharmacies, Belmar, received an FDA warning letter issued 31 March 2023 (posted 18 April 2023), addressed to “Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy”, over compounding practices — and FDA closed that letter out on 30 October 2023. Pallas itself carries no warning letter
- Only two clinicians are named across the whole site, and the footer's “Provider directory” link resolves to a section naming the same two. The actual prescribing network — Lion MD's affiliated professional corporations — is not published, and Pallas states that it is a technology platform and does not employ medical providers
- The headline numbers are intro rates, and the sitewide “Up to $120 off your first month” banner is a discount rather than a price. Read the money terms before paying: $5 is deducted from each refunded payment for purchases made on or after 14 July 2026 (never on clinician-declined or unfulfilled orders, which refund in full), and the $60 visit deposit can be retained if you neither attend nor reschedule the required video visit in the eight jurisdictions that need one — otherwise it is refunded and credited to the first order
- Cash-pay only, with no insurance ever accepted, and brand-name at $1,069–$1,349/mo (Zepbound, Ozempic, Wegovy, Mounjaro) is far above what an insured patient pays. The compounded semaglutide and tirzepatide are not FDA-approved and are not generic equivalents, which Pallas does disclose properly
- Several things a buyer would want are simply not published: whether baseline or follow-up lab work is included or charged extra, and whether the price rises with dose (there is no pre-purchase dose selector). The footer states that some site content is AI-generated with no warranty of accuracy, so its blog is not a source for a clinical claim; the advertised “4.8” rating carries no published source; and the before-and-after “Verified Customer” stories carry Pallas's own caveat that individuals shown may be actors or models
The bottom line
Best for: Readers who want a general compounded GLP-1 program with unusually specific disclosure about who prescribes and who dispenses, and who can absorb a $597 charge four weeks after the $139 one — not readers looking for PCOS or perimenopause care, which Pallas does not offer. Names its six dispensing pharmacies and two NPI-verified physicians — disclosure few rows here offer — and then sells the whole thing on a single 12-week prepay whose advertised “$199/mo average” is that prepay divided by three, with no monthly rung to pick instead.
Ranked #16 of 65 providers we reviewed for women — see our #1 pick, CoreAge Rx, for comparison. PCOS & hormonal suitability is where Pallas Health scores lowest, at 74/100. If that is your sticking point, start with our ranked shortlist of Pallas Health alternatives.
Compare with other providers
All 64 other providers we've reviewed for women, in our overall ranking order. One of those comparisons is written out in full: Pallas Health against CoreAge Rx, factor by factor, 11 points apart on the Luna Fit Score. Directly below Pallas Health sits Vytora Health at #17 with 87/100 — see the alternatives to Vytora Health we rank for women if that is the band you are shopping in.
- #1CoreAge Rx— The most reliable on-ramp for women: nationwide access to both molecules at one flat, no-surprise price — including tirzepatide, the option many women with insulin resistance want.93/100
- #2Enhance MD— A tiered compounded program that lays every price on the table — semaglutide, tirzepatide, a microdose lane, and a combo option — with six-month metabolic lab testing and an NAD+ adjacency that speaks to women thinking about metabolism as a whole system.92/100
- #3yourEra— Both molecules at prices you can see up front, wrapped in a wider menu — NAD+, microdosing, and an optional coaching-and-labs bundle — for a woman who wants weight care and energy alongside it.86/100
- #4Sesame Care— An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.85/100
- #5HealthRX— A LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injections — both molecules, transparent no-insurance pricing, and an accreditation signal that reassures when hormones are in play.85/100
- #6MadeMed— A LegitScript-verified compounded program that charges one flat price at every dose — so titrating up to a working dose never quietly raises the bill.84/100
- #7Trimi— Among the lowest verified prices we log — compounded semaglutide and tirzepatide on a single membership, shipped nationwide. A budget-first on-ramp for women who want tirzepatide access without paying a premium.84/100
- #8Found— An insurance-first GLP-1 marketplace that shops a reader's coverage for her — down to $99/mo with qualifying insurance, or $50/mo for eligible Medicare Part D members through its CMS Bridge program — with one of the widest medication menus in this ranking, including an oral pill option.84/100
- #9ShedRx— A weight-focused program that also offers an oral/sublingual route — a genuine relief for the needle-averse and for anyone easing in gradually.83/100
- #10Strut Health— One of the few programs with a women's weight-loss line of its own, and the widest set of routes we track — injectable or sublingual, semaglutide or tirzepatide, each with its price on the page.83/100
- #11Telos Rx— One of the deepest catalogs we log for a woman managing metabolism and hormones together — semaglutide and tirzepatide in oral, microdosed, and injectable forms, plus bioidentical HRT and a long peptide menu, from a LegitScript-certified, HIPAA-compliant compounder.83/100
- #12Gala Health— A GLP-1 program built explicitly for women — its product pages say so, and it sells HRT and menopause care beside the weight-loss line, which is a genuine draw if you are managing metabolism and hormones together. The $179 entry is real, but it is a yearly-subscription rate; no month-to-month price is published.83/100
- #13Eden— A high-transparency program with unusually clear clinician and supply-chain disclosure — you can see who is prescribing and where the medication comes from, which is rarer than it should be.88/100
- #14Sprout Health— A LegitScript-certified desk that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.82/100
- #15Ondra Health— A rare combination for the price-conscious woman: rock-bottom compounded pricing on both molecules, an FDA-approved brand path, and LegitScript accreditation — a lot of clinical reassurance for very little money.88/100
- #17Vytora Health— One of the few accredited programs pairing FDA-approved brand access with compounded on both molecules, nationwide — reassuring when you want a real clinical path for hormonal metabolic care.87/100
- #18System Labs— A flat $179 a month at every dose, with the ongoing rate stated in writing rather than buried under an intro price — and you can cancel from your own dashboard, which is more than most of this ranking will commit to.81/100
- #19RxSpan MD— One of the very few programs here that will tell you who compounds your medication and who signs the prescription — four pharmacies named with phone numbers, two physicians named with NPIs that resolve — wrapped around a full menu that runs from compounded semaglutide to brand Zepbound.81/100
- #20Effecty— An accredited, brand-capable program with mid-market pricing on both molecules — a balanced pick when you want FDA-approved options on the table alongside compounded.87/100
- #21Lttl— Publishes more of its pricing than anything else in this ranking — all 70 rungs, in the open, each labeled with what it actually bills — and then prints the same wrong “from $129/mo” on all fourteen product cards, four of which it would overcharge.81/100
- #22Vaylen— One of the most complete feature sets we review for women: both molecules, an oral option, FDA-approved brand access, and LegitScript accreditation, all nationwide.87/100
- #23Tyde Wellness— An accredited, all-50-states program that offers an oral option alongside injections — real flexibility for a woman easing into GLP-1 care.86/100
- #24Gimme Care— Affordable, accredited, and nationwide — an easy on-ramp for a woman who wants tirzepatide at a fair price without sacrificing an oversight signal.86/100
- #25Direct Meds— One of the few programs we track that offers an oral or sublingual route alongside injections — semaglutide drops from about $179 (or $297 injectable), tirzepatide from about $224 — all-inclusive with no separate membership. The trade-off is a newer, less-verified operator whose prices we couldn't confirm live.80/100
- #26Precision Telemed— A straightforward accredited telehealth option with fair pricing on both molecules and nationwide reach — a solid middle-of-the-road choice.86/100
- #27Care Bare Rx— One of the few programs here that puts both molecules in an oral form as well as an injection, alongside a real brand-name Ozempic lane — and it names the physicians behind the prescription, which few rows here do.80/100
- #28Ro— A heavyweight platform with brand-name (Wegovy/Zepbound) access and insurance navigation — powerful if you want an FDA-approved product, but compounded pricing is opaque.86/100
- #29BetterMe Rx— A wellness-app lineage brings a behavior-change sensibility to GLP-1 care — with an oral option and accreditation, though pricing sits mid-market.86/100
- #30PepHaūs— A straightforward accredited telehealth program with both molecules nationwide — dependable middle-of-the-road care with a real oversight signal.85/100
- #31REMEVi— An accredited nationwide program with both molecules — solid oversight, though pricing sits toward the higher end.85/100
- #32NiceRx— An accredited, nationwide program with predictable mid-market pricing on both molecules — a dependable if unremarkable choice.85/100
- #33AgelessRx— A longevity-leaning brand whose hormone and healthy-aging catalog speaks directly to the perimenopause transition — plus some of the lower semaglutide pricing.84/100
- #34Invigor Medical— An established telehealth pharmacy with a broad metabolic and hormone catalog — handy if you want GLP-1 care inside a wider hormonal-wellness program.84/100
- #35Curex— Identical pricing on both molecules plus an oral option from an accredited platform — appealing if you want to switch between semaglutide and tirzepatide without a price penalty.84/100
- #36Elara Health and Wellness— Low pricing on both molecules nationwide — attractive on cost, though the lack of LegitScript accreditation makes the oversight signal thinner.84/100
- #37Cora Health— Unusually specific about who fills the prescription: two PCAB-accredited compounding pharmacies named outright, a LegitScript ID you can look up, and a flat price at every dose with no membership fee bolted on.84/100
- #38Fitish— An accredited, women-friendly brand offering an oral route nationwide — the trade-off is premium pricing on both molecules.84/100
- #39Henry Meds— A flat-fee compounded pioneer — a simple, well-known model, but priced at the higher end now with no hormone-specific angle.83/100
- #40Hims & Hers— The Hers side is one of the few mass-market brands built around a women's identity — app-first, nationwide, though its hormonal depth is thin.83/100
- #41Breeze Meds— A straightforward nationwide compounded program with NAD+ alongside the GLP-1 line — but it publishes one headline price and very little else.77/100
- #42Alloy— The only program in this ranking built for midlife first: your prescriber is a Menopause Society–certified physician, and weight care sits alongside a full hormone-therapy line rather than being sold in isolation.82/100
- #43Synergy Rx— One of the few programs here that will prescribe brand-name Wegovy, Ozempic or Mounjaro when clinically appropriate, with unlimited 24/7 access to its clinical team — though you will not find a GLP-1 price anywhere on its site.76/100
- #44Bodybuilding Health+— The Bodybuilding.com brand's new compounded-telehealth arm publishes both ladders openly — semaglutide really does fall from $179/mo to $139/mo if you prepay a year, while its tirzepatide bundles cost MORE per month than its $209 month-to-month rate — wrapped around a deep sermorelin, NAD+, and peptide menu; real value on one molecule if you go in clear-eyed that it's compounded, brand-new, and final-sale.76/100
- #45Mochi Health— A genuinely support-forward weight-care program with a strong care team — but limited state coverage and no accreditation weigh it down here.81/100
- #46Embody— The cheapest month-to-month price in the ranking by a wide margin, from a program that names all four of its compounding pharmacies — with the catch that it is a starting-dose promotional rate against a $299 list price, so it is the figure most likely to move.81/100
- #47MyDrHank— A flat, all-dose price on both molecules — including the tirzepatide most insulin-resistance readers are actually here for — from a general telehealth shop that publishes its ladder openly but shows you only the twelve-month rung of it.73/100
- #48Try Ageless— Three routes on one plan — semaglutide or tirzepatide by injection, or tirzepatide as sublingual drops if needles are the thing stopping you — with the dispensing pharmacy and the prescribing physician both named, and the physician's NPI actually resolving.73/100
- #49Peter MD— A physician-prescribed telehealth brand (Miami, founded 2021) that puts GLP-1 care on the same account as TRT, ED, NAD+, sermorelin and hair loss — genuinely broad, but built for a general and largely male-first audience rather than PCOS or hormonal care specific to women.72/100
- #50Oak— A compounded program sold as one-off packages rather than a subscription, in Spanish as well as English — but its own pages give nine different starting figures, none of them carrying a term, no price you can rely on until you have finished a 29-question intake, and two different answers on how many states it serves.72/100
- #51SkinnyRx— The rare program that compounds tirzepatide as a dissolving tablet as well as an injection — genuinely useful if the needle is what is stopping you — sold behind a four-rung commitment ladder whose cheapest rung is the only price the site ever shows you.71/100
- #52Measured— The clearest pricing structure in the ranking — compounded plans are all-in and month-to-month, brand plans say plainly that the drug is billed separately — paired with a dietitian and an insurance team, for the quarter of the country it actually covers.77/100
- #53Good Girl Rx— A women-first brand with the clearest contraception guidance we found anywhere in this ranking — and an FDA warning letter for how it labeled its compounded products, which is the reason it does not rank higher.76/100
- #54Live Vital— A one-physician practice whose founder is menopause-certified and has written a 40-page perimenopause guide — genuine midlife expertise, wrapped around the most misleading price presentation in the ranking.76/100
- #55SnagRx— Holds one price at every dose and names all four of its partner pharmacies with addresses — a rare pair of disclosures, wrapped in discount theater that does not survive a second look.70/100
- #56Nolu— A wellness-lifestyle brand, not positioned around either gender, selling both molecules plus a named Microdose GLP-1+B12/NAD+ stack in two variants at one all-in price — with no named clinician or pharmacy behind any of it.75/100
- #57HealthSource— One of the few programs that documents its all-50-state footprint rather than asserting it, with an oral tirzepatide route and a starter-dose plan priced the same as the full dose.74/100
- #58WellMedr— A genuinely broad low-dose menu — eight microdose formulations, four of them oral, on top of both injectable molecules and a priced brand path — wrapped around a price you cannot pin down: the $59 and $99 headlines are conditional, and the rate you would actually be charged month to month appears nowhere before the medical intake.67/100
- #59Cielo— A deliberately narrow program — two GLP-1s and nothing else, no hair, no testosterone, no upsells — priced the same at every dose, but it publishes neither its coverage map nor its cancellation terms.73/100
- #60Fresh Day Meds— Publishes its entire plan matrix in its own subscription terms — every tier, every dose band, every billing cadence — and then locks your price when the dose goes up, which is rarer than it sounds.71/100
- #61MyFastRx— The best-documented exit terms we found — it publishes a worked example of how a canceled prepay is recalculated — attached to a site that still has last season's prices live on the same pages as this season's.68/100
- #62FORM (by GBY)— The broadest catalog in this ranking — compounded and brand-name semaglutide and tirzepatide, a named microdose tirzepatide product, NAD+, sermorelin and hair loss — with almost none of it priced before you start an intake.68/100
- #63Mint Med— Names the physician who reviews every intake and locks your price for life across every dose — then undercuts both promises with a banner price that matches nothing on sale and a refund policy that contradicts the storefront.65/100
- #64NewSelf— One price at any dose, three months of medication shipped up front — and a set of exit terms and unresolved compliance problems that make it the hardest program in this ranking to leave.64/100
- #65Glam Health— A beauty-adjacent brand name over gender-neutral copy, with the least verifiable pricing and the thinnest trust signals of any row in this ranking — no LegitScript badge, no named clinician or pharmacy, and no published state list.55/100
Pricing, states and verification reflect Pallas Health's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on Pallas Health's site. Not medical advice; see our disclosure.